← FDA Drug Approvals (Drugs@FDA)

SUTENT

NDA · New Drug Application · Sponsor: CPPI CV · Approved 2006-01-26

Drug application

FDA Application #

NDA021938

Application type

New Drug Application

Brand name

SUTENT

Generic name

SUNITINIB MALATE

Active ingredients

SUNITINIB MALATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

CPPI CV

Manufacturer

U.S. Pharmaceuticals

First approval

2006-01-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown